Arrow Financial’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-13,997
| Closed | -$1.39M | – | 339 |
|
|
2019
Q3 | $1.39M | Sell |
13,997
-757
| -5% | -$71.9K | 0.29% | 77 |
|
|
2019
Q2 | $1.36M | Buy |
14,754
+10
| +0.1% | +$950 | 0.29% | 75 |
|
|
2019
Q1 | $1.39M | Sell |
14,744
-120
| -0.8% | -$10.5K | 0.32% | 76 |
|
|
2018
Q4 | $953K | Sell |
14,864
-4,715
| -24% | -$348K | 0.24% | 89 |
|
|
2018
Q3 | $1.75M | Sell |
19,579
-551
| -3% | -$48.7K | 0.37% | 67 |
|
|
2018
Q2 | $1.6M | Sell |
20,130
-437
| -2% | -$36.3K | 0.36% | 72 |
|
|
2018
Q1 | $1.83M | Sell |
20,567
-1,920
| -9% | -$184K | 0.43% | 63 |
|
|
2017
Q4 | $2.35M | Sell |
22,487
-822
| -4% | -$92.8K | 0.54% | 51 |
|
|
2017
Q3 | $3.4M | Sell |
23,309
-388
| -2% | -$52.9K | 0.81% | 34 |
|
|
2017
Q2 | $3.08M | Sell |
23,697
-510
| -2% | -$62.5K | 0.74% | 39 |
|
|
2017
Q1 | $3.01M | Sell |
24,207
-1,189
| -5% | -$142K | 0.73% | 38 |
|
|
2016
Q4 | $2.94M | Sell |
25,396
-1,049
| -4% | -$117K | 0.73% | 38 |
|
|
2016
Q3 | $2.76M | Sell |
26,445
-1,013
| -4% | -$110K | 0.7% | 39 |
|
|
2016
Q2 | $2.71M | Sell |
27,458
-5,502
| -17% | -$569K | 0.71% | 44 |
|
|
2016
Q1 | $3.3M | Buy |
32,960
+735
| +2% | +$75.7K | 0.88% | 33 |
|
|
2015
Q4 | $3.86M | Sell |
32,225
-338
| -1% | -$39.1K | 1.03% | 29 |
|
|
2015
Q3 | $3.52M | Buy |
32,563
+620
| +2% | +$76.9K | 1% | 29 |
|
|
2015
Q2 | $3.7M | Sell |
31,943
-608
| -2% | -$69.5K | 1% | 32 |
|
|
2015
Q1 | $3.75M | Sell |
32,551
-2,946
| -8% | -$352K | 1.01% | 30 |
|
|
2014
Q4 | $3.97M | Buy |
35,497
+984
| +3% | +$104K | 1.08% | 27 |
|
|
2014
Q3 | $3.27M | Sell |
34,513
-279
| -0.8% | -$25.2K | 0.91% | 34 |
|
|
2014
Q2 | $2.99M | Sell |
34,792
-560
| -2% | -$42.6K | 0.81% | 34 |
|
|
2014
Q1 | $2.47M | Sell |
35,352
-3,420
| -9% | -$271K | 0.7% | 45 |
|
|
2013
Q4 | $3.27M | Buy |
38,772
+4,270
| +12% | +$338K | 0.94% | 23 |
|
|
2013
Q3 | $2.66M | Sell |
34,502
-400
| -1% | -$28K | 0.82% | 34 |
|
|
2013
Q2 | $2.04M | Buy |
+34,902
| New | +$2.1M | 0.65% | 49 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Arrow Financial's CELG Position: Q4 2019 in Review
Arrow Financial sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 13,997 shares — an estimated $1.39M sold.
Arrow Financial first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $3.97M in Q4 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Arrow Financial reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Arrow Financial sold 13,997 Celgene Corp shares in Q4 2019, an estimated $1.39M.
- Arrow Financial first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Arrow Financial's Celgene Corp position peaked at $3.97M in Q4 2014.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Arrow Financial's 13F filing for Q4 2019, filed 10 Feb 2020.